Our results revealed no major difference in ATG9B, BECLIN1, LC3B, NIX, and SQSTM1 mRNA expression between tumor and healthy adjacent tissues, but we observed an increase in ATG9A mRNA expression in Luminal A, Luminal B and TN patients, even if the significance of these differences remained to be confirmed. The gene discussed is MAP1LC3B; the disease is neoplasm.